Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

NACompletedINTERVENTIONAL
Enrollment

698

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

July 15, 2025

Study Completion Date

July 15, 2025

Conditions
Acute Kidney Injury
Interventions
OTHER

Level A

Pharmacy personnel will generate a general recommendation based on the AKI KDIGO management guidelines to the physician.

OTHER

Level B

The pharmacist will make nephrotoxic/renally eliminated medication management recommendations to the attending physician (or designee). Recommendations may include stopping or changing a drug, changing dose or schedule, ordering laboratory tests, taking no action, or other. The pharmacist will record details of the interaction with the physician and whether recommendations were accepted.

OTHER

Passive Alert

Passive Cerner alert provides decision support within the EMR for the diagnosis and basic staging of AKI but without specific recommendations for management.

Trial Locations (8)

15132

UPMC McKeesport, McKeesport

15213

UPMC Magee, Pittsburgh

UPMC Presbyterian/Montefiore, Pittsburgh

15232

UPMC Shadyside, Pittsburgh

16105

UPMC Jameson, New Castle

16121

UPMC Horizon, Farrell

16601

UPMC Altoona, Altoona

17701

UPMC Williamsport, Williamsport

All Listed Sponsors
collaborator

University of Florida

OTHER

collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pittsburgh

OTHER

NCT06264752 - Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury | Biotech Hunter | Biotech Hunter